Objectives: To assess the effect of the menstrual cycle and pregnancy on whole body protein turnover. Design and subjects: Whole body protein turnover was determined using oral [
Introduction
There is variability amongst individuals in the requirements for nutrients, which is about 25% for protein (FAOa WHOaUNU, 1985) . In addition, there are for women changes associated with the menstrual cycle and with pregnancy. Normal women experience the cyclical effects of female hormones, which have been associated with changes in food intake, body weight, basal metabolic rate, and losses of nitrogen in urine and stool and from the skin (Calloway & Kurzer, 1982; Dalvit, 1981; Bisdee et al, 1989a; Solomon et al, 1982) . As pregnancy progresses there are extensive metabolic changes with time as the metabolism of the mother accommodates to the demands of the developing foetus and prepares for lactation. Weight gain is a normal feature of pregnancy. Net protein accretion is estimated to be 925 g over the 9 months of gestation (Hytten & Leitch, 1971) , to account for the laying down of fetal and placental tissues, as well as the increase in maternal blood volume and maternal tissues. The greatest accretion of protein is thought to occur in the last quarter, at a rate estimated to be 6.1 g protein per day. These estimates of requirements form the basis of recommendations, suggesting that additional dietary protein is needed by women throughout their pregnancies (FAOaWHOa UNU, 1985) . However, there is little evidence to show that women increase their protein intake as pregnancy advances. In a careful prospective study of 538 pregnant women in Southampton, protein intake decreased from 87.2 to 85.7 g between mid and late gestation (Godfrey et al, 1996) . As nitrogen balance studies during pregnancy suggest that the retention of nitrogen might be even greater than the estimates of net accretion (Calloway, 1974) , the implication is that the mother's metabolism adapts to the altered demands.
Net protein accretion requires that the rate of protein synthesis exceeds the rate of protein degradation and substantial changes in the balance between these rates can be achieved which are not obviously related to changes in the dietary intake of protein (Waterlow, 1995) . Hence, the determination of whole body protein turnover can provide an understanding of changes in the dynamics of protein metabolism and it has been reported during the course of pregnancy in three studies; in Jamaica (de Benoist et al, 1985) , The Gambia (Willommet et al, 1992) and the UK (Thompson & Halliday, 1992) . Each of these studies used a different method to measure protein turnover and each obtained slightly different results. In two studies [ 15 N]glycine was used as the isotopic tracer, given either as prime-intermittent oral doses (de Benoist et al, 1985) , or as a single oral dose (Willommet et al, 1992) , with turnover being derived from the enrichment in urine of the end products of metabolism, urea and ammonia. Women stud-ied in The Gambia had rates of protein turnover that were highest in the 2nd trimester, decreasing as pregnancy advanced (Willommet et al, 1992) . In contrast, pregnant Jamaican women were found to have the highest rate of turnover in the 1st trimester, with a gradual decline over pregnancy (de Benoist et al, 1985) . The study carried out in English women used a continuous intravenous infusion of 13 C leucine, and when the results were expressed in relation to total body weight the rates of protein turnover changed little as pregnancy progressed (Thompson & Halliday, 1992) . Therefore, it is not possible to know whether the ®ndings re¯ect real biological differences of mothers in very different situations or might be accounted for by differences in the methods used. Resolution of this dilemma is important. A signi®cant body of epidemiological evidence shows relationships between the risk of developing disease such as cardiovascular disease and type 2 diabetes in later life and the size and shape of a newborn baby within the normal range of variation (Barker, 1998) . The growth of the foetus is dependent upon the delivery of energy and nutrients from the mother. The available evidence shows modest associations between dietary intake during pregnancy and size at birth (Godfrey et al, 1996; Mathews et al, 1999) . There is however, evidence of a stronger relationship between the growth of the fetus and the nutritional status of the mother at the time she becomes pregnant, when nutritional status is characterized as her body size and composition (Kramer, 1987; Langhoff-Roos et al, 1987) .
Of the different ways in which protein turnover might be measured, only one approach is non-invasive and is readily applicable to free-living people, the single doseaend product method (Fern et al, 1984 (Fern et al, , 1985a , used in the study in The Gambia (Willommet et al, 1992) . We have determined the limits of the application of this method under different conditions in normal men (Grove & Jackson, 1995) , but there are no reports which explore the application of this method in women. Therefore, we have carried out a series of studies in normal women to determine the extent to which the single doseaend product method provides results which compare with the prime-intermittent doseaend product method following the oral administration of [
15 N]glycine. A further objective was to determine the magnitude of any effect on protein turnover of the menstrual cycle. We have made preliminary measurements on women at two stages in pregnancy using this non-invasive method, in order to compare the results with those results obtained in pregnant English women using intravenous infusions of [ 13 C]leucine (Thompson & Halliday, 1992) .
Methods

Subjects
Ethical approval for the study was received from the joint ethical committee of the Southampton Hospitals and the South West Hampshire Health Authority. The subjects agreed to participate when the nature of the study was explained to them. The study was carried out in three parts. The urine was acidi®ed with 25 ml HCI, 6 molal, the volume measured and an aliquot stored at 7 20 C. For each subject 20 ml of venous blood was drawn from an antecubital vein into a heparinized container, 9 h after the ingestion of the isotope. The blood was centrifuged at 2500 g for 20 min, the plasma removed and stored at 7 20 C. The blood sample was used to determine the amount of labelled urea retained in the urea pool at 9 h.
Intermittent dose approach: a urine collection was made between 21:00 h and midnight for the measurement of baseline enrichment. At midnight a priming dose of [ 15 N]glycine, equivalent to 18 h of intermittent dosage (0.09 mg Nakgah), was taken orally dissolved in water. From 06:00 h, intermittent doses of [
15 N]glycine were taken every 3 h (equivalent to 0.005 mg Nakgah) until 1800 h. Urine was collected at 3 h intervals until 21:00 h. The urine was acidi®ed with 25 ml HCI, 6 molal, the volume measured and an aliquot stored at 720 C.
Study 2. In nine normal adult females, protein turnover was determined using a single oral dose of [ 15 N]glycine, with measurements of enrichment in urinary ammonia over 9 h. Measurements were made at two stages of the menstrual cycle, on day 7 and day 14 following the onset of the last period of menstruation. Day 7 was selected as a time point when hormonal levels were likely to be at a low level, and day 14 as being around the time of ovulation when circulating levels of oestrogen, progesterone, follicle stimulating hormone and luteinizing hormone would be rising or near to maximum. The subjects were members of the scienti®c staff and three were taking the contraceptive pill at the time of the study. The studies were carried out at intervals of 3 or 5 weeks.
Urine was collected between 06:00 h and 09:00 h for the measurement of background abundance. A single dose of [ 15 N]glycine (99 atoms per cent excess, Cambridge Isotope Laboratories, Massachusetts), 200 mg made up in water, was taken orally at 09:00 h. Urine was collected between 0900 h and 1800 h. The urine was acidi®ed with 10 ml HCI, 6 molal, the volume measured and an aliquot stored at 720 C.
Study 3. Five pregnant women were recruited from the booking clinic of the Princess Anne Maternity Hospital, Southampton, between 12 and 16 weeks gestation. They were multiparous, non-smokers, of similar height but a range of body weight. Measurements of protein turnover were made at 17 ± 20 weeks gestation, and again at 30 ± 32 weeks gestation, using a single oral dose of [ 15 N]glycine and measurement of enrichment in ammonia and urea in urine collected over 24 h. Fat mass was derived from skinfold thickness measured at four sites (Durnin & Womersley, 1974) and fat-free mass was calculated as body weight minus fat mass. :00 h and 09:30 h. Urine was collected for the next 24 h. The urine was acidi®ed with 10 ml HCI, 6 molal, the volume measured and an aliquot was stored, at 720 C.
Diets
The habitual dietary intake of each subject was assessed using a 3 day food diary based upon household measures, and energy and protein intakes were determined using standard food portion sizes and a computerized dietary analysis package based upon McCance and Widdowson's Food Composition Tables (Holland et al, 1991; Crawley, 1992) . In the non-pregnant females, the food intake was standardized on the day of study and provided as regular meals every 3 h, so that over the day the consumption of protein was 1.1 ± 1.2 gakgaday, and the habitual intake of energy (between 8 and 11 MJaday) was approximated. The pregnant women were provided with food to match their reported intake, but were allowed to consume to appetite, with a record being kept of all food that was consumed.
Analyses
The concentrations of urea nitrogen and of ammonia nitrogen in urine were assayed by the Berthelot method (Kaplan, 1965) . Ammonia was isolated from urine by alkaline aeration. The ammonia-free urine was then reacted with urease (EC 3.5.1.5; Jack Bean Type III) to liberate urea nitrogen as ammonia, which was collected by alkaline aeration (Jackson et al, 1980) . Alkaline hypobromite was used to liberate nitrogen gas for entry into the mass spectrometer and enrichment was measured with a triple collector isotope ratio mass spectrometer (Sira 10, VG Isogas, Middlewich, Cheshire). The concentration of urea in plasma was determined by an automatic method (TechniconaBayer Smac 2 Analyzer, using the diacetyl monoxime method). The total body urea pool was derived on the assumption that urea was distributed throughout total body water. Total body water (TBW) was estimated using the equation of Watson et al (1980) :
where age is in years, height is in cm and mass is in kg. Plasma samples were deproteinized with an equal volume of perchloric acid, 775 mmolal, and the urea nitrogen was extracted and isolated from the deproteinized plasma for the measurement of enrichment, using the same approach as for urine (see above).
Calculations
For the prime-intermittent dose studies plateau enrichment in urinary ammonia and urea was determined by visual inspection. The level of enrichment at plateau was used to calculate nitrogen¯ux (Picou & Taylor-Roberts, 1969) :
where Q is¯ux, d is the rate of administration of 15 Nglycine and En is the enrichment at plateau in the end product, urea or ammonia.
For the single dose studies in non-pregnant women,¯ux was derived from the amount of isotope recovered in the end product in urine over a 9 h period. In principle the method requires that the period of time over which recovery of isotope is measured is that required to ensure that the isotope has been completely cleared from the body pool of the end product. There is no a priori method of knowing the most appropriate time over which urine should be collected to ensure that the body pool has been completely cleared. Previous experience has suggested that a period between 9 and 12 h might be suitable for ammonia, with a longer period being required for urea (Fern et al, 1984; Grove & Jackson, 1995) . Flux was derived from the amount of label recovered in the urine over 9 h for ammonia. For urea, some of the label will be recovered in urine at the end of 9 h, but a signi®cant proportion will still be retained in the body's urea pool. The amount of urea retained was derived from the enrichment of plasma urea and the size of the urea pool. The size of the urea pool was estimated from the concentration of urea in plasma and total body water, on the assumption that urea is evenly distributed throughout total body water.
Flux was calculated by the method of Waterlow et al (1978) and Fern et al (1985b) :
where Q is¯ux, d is the amount of isotope administered, E x is the amount of ammonia-N or urea-N excreted and e x is the amount of isotope excreted as ammonia-N or urea-N over the period of study. When urea is used as the end product to calculate¯ux at 9 h, e x includes the amount of isotope retained in the urea pool at 9 h. In pregnant women urine was collected for 24 h, to allow for the total clearance of labelled urea from the body pool. Therefore, for the pregnant women E x is the amount of ammonia-N or urea-N excreted over 24 h and e x is the amount of isotope excreted as ammonia-N or urea-N over 24 h (Grove & Jackson, 1995) . Protein turnover in normal women AA Jackson et al
Statistical analyses
Differences between sets of data were sought by the use of the Mann ± Whitney U-test or t-test for paired data and differences were taken to be statistically signi®cant when P`0.05. The results are reported as the mean (s.d.).
Results
Study 1
The women were aged 22.6 (0.8) y, were 1.67 (0.56) m tall and weighed 59.0 (5.2) kg, having a body mass index of 21.0 (1.8) kgam 2 . For the prime-intermittent dose study enrichment in urinary ammonia achieved plateau in samples collected between 12:00 h and 21:00 h, and the variability of values at plateau was on average 14%. Plateau enrichment was achieved in urinary urea over the same period of time, with variability being 11% on average. Table 1 shows the values for protein turnover, protein synthesis and protein degradation for the studies in which either the single dose or the prime-intermittent dose method was used. When calculated from the enrichment in urea, ux tended to be greater than when calculated from enrichment in ammonia. When compared with the primeintermittent dose method,¯ux tended to be greater with the single dose method, regardless of the end product used. Thus, the average rate of protein turnover using the primeintermittent dose method was only 81% that using the single dose method, and this difference was re¯ected in the values for protein synthesis and protein degradation. The difference in protein turnover amongst the different methods was only signi®cant for the extremes, that is the difference between¯ux derived from the single dose method with ammonia as the end product, and from the prime-intermittent dose method with urea as the end product (P`0.05). In Figure 1 the results obtained in the present study are compared with results obtained in a previous study in men in which identical methods were used (Grove & Jackson, 1995) . It can be seen that the results are comparable between men and women for any one method, and any differences are more likely to be due to differences in the method used than to differences in gender.
Study 2
The characteristics of the women are shown in Table 2 . There were no differences for age, height, weight or body mass index between the women not taking the pill and the women taking the pill. In the women not taking the pill there was a signi®cant difference between¯ux, synthesis and degradation measured at day 7 compared with day 14, with the values for¯ux on day 14 being about 20% higher (P`0.05). The individual changes are shown in Figure 2 . For the women taking the pill there was no difference in any aspect of protein turnover between day 7 and day 14. At day 14 there was a signi®cant difference for¯ux, synthesis and degradation between the women not taking the pill and the women taking the pill (P`0.05). (Grove & Jackson, 1995) . Signi®cantly different from ammonia in prime-intermittent dose method (P`0.05). Table 2 The age, height, weight and body mass index of women in whom protein turnover was measured, six of whom did not take the contraceptive pill and three of whom did, at day 7 and day 14 of the menstrual period Non-pill Pill (n-6) ( n-3) P-value 
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Study 3
We have previously shown that the value derived for protein turnover is sensitive to the experimental conditions adopted, and the most robust approach appears to be to use the average value obtained from ammonia and urea as the end product, with at least 12 h collection of urine for ammonia and 12 h collection of urine for urea, with a blood sample to determine the amount of label retained within the urea pool (Grove & Jackson, 1995) . The urea retained within the urea pool at 12 h is passed in the urine over the following 12 h. Therefore, an alternative to taking a blood sample at 12 h is to collect urine from 12 to 24 h and measure the recovery of label in urea (Grove & Jackson, 1995) . This is the approach which was adopted for the pregnant women as it removes the need for a sample of blood. In Table 3 , the characteristics of the women at the two stages of pregnancy are shown. The women were around 29 y of age. Between 18 and 31 weeks of pregnancy they gained 8.5 kg in weight (P 0.001), which comprised a signi®cant increase in fat-free mass of 4.3 kg (P 0.013) and a change in body mass index of 3.1 kgam 2 (P`0.001). The consumption of energy between these times increased by 1.5 MJaday and for protein by 0.8 gaday, hence the proportion of energy derived from protein decreased from 14.4% at 18 weeks to 12.8% at 31 weeks. These differences were not statistically signi®cant.
The values for protein kinetics during pregnancy are shown in Table 3 , based upon the end-product average (Fern et al, 1985b) . There was a signi®cant decrease in the rate of nitrogen excretion across gestation (P 0.003) when the results were expressed relative to body weight. Figure 4 Whole body protein synthesis at different stages of pregnancy, compared with non-pregnant women has been reported in four different studies, from Jamaica (de Benoist et al, 1985; . The Gambia (Willommet et al, 1992 u) , England (Thompson & Halliday, 1992; *) , and the present study (s).
The panel on the left shows the results as reported by the authors, and the panel on the right shows the results of the same studies which have been adjusted to take account of methodological differences.
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There was a modest, but signi®cant increase of 7 ± 12% in the rates of nitrogen¯ux, protein synthesis and protein degradation between mid and later pregnancy (P`0.05), Figure 3 . Much of this difference could be associated with increased body mass, because the rates of nitrogen¯ux, protein synthesis and protein breakdown remained similar between mid and late pregnancy when expressed relative to body weight or fat-free mass.
Discussion
We have carried out a series of studies in which women have been given oral doses of [ 15 N]glycine either as a single oral dose or prime-intermittent oral doses, and have measured the enrichment in urea and ammonia in urine. The objective of the work has been to determine the extent to which values derived for whole body protein turnover using this approach could be considered reliable and whether the method could be used for the study of protein kinetics during pregnancy. In the ®rst study, the`single dose' method was compared with the`prime-intermittent' dose method in the same women, using both urea and ammonia as end products. The results are identical to those which have been obtained in men, and therefore it can be presumed that the same conditions and limitations apply to the method when used in women as when used in men (Grove & Jackson, 1995) . Pannemans et al (1995) compared protein synthesis in young men and women while consuming either 1.0 day or 1.8 g proteinakgaday. They found on the lower and higher protein intakes, synthesis in women was 23.3 and 28.0 mg Nakgaday, and for men was 27.3 and 30.7 mg Nakgaday, and concluded that there were no signi®cant differences between the genders. In the single dose method, the time period over which urine is collected makes an important difference to the absolute values obtained for protein turnover: the longer the period of collection, the lower the derived value for nitrogen¯ux (Grove & Jackson, 1995) .
The end product method has the great advantage of being non-invasive, but it is sensitive to error and on the basis of the present results and those of our earlier study in men (Grove & Jackson, 1995) we conclude that standardizing the period over which urine is collected is especially important. The duration of urine collection should be long enough to allow the label to be cleared from the body pool, but not so long that there is the likelihood of signi®cant return of label to the pool from the degradation of protein (Fern et al, 1984 (Fern et al, , 1985a . The lower limit is identi®ed as the time required to clear the ammonia pool of labelled ammonia, and we have found that for men 9 h is likely to be too short, with a period of 15 ± 18 h being preferable. The upper limit is identi®ed as the time required to clear the urea pool, which is adequately achieved within 24 h, and at this time there has not been signi®cant return of label to the pool (Grove & Jackson, 1995) . The importance of the need to standardize the approach is shown in Figure 4 , where measurements of protein turnover in pregnancy, using different methods, has been compared. For the study in The Gambia, the single dose [
15 N]glycine method was used with enrichment being measured in urinary ammonia and urea collected over 9 h, and for urea in blood at 9 h (Willommet et al, 1992) . The results of the non-pregnant women in The Gambia and England (Study 1 in the present work, Table 1 ) in which the same method has been used, can be compared directly. Based on the end-product average, for women in England, nitrogen¯ux was 38 mg Nakgah and protein synthesis was 31 mg Nakgah, and for women in The Gambia nitrogen¯ux was 36 mg Nakgah and protein synthesis was 30 mg Nakgah. Therefore, when the same method was used in women in the same physiological state in the two different situations, the results were similar. The results of Study 1 would suggest that there is a relative overestimate of about 20% when the single dose end product method is used over 9 h, compared with either the prime-intermittent dose method, or the single dose method with periods of urine collection for ammonia of 12 ± 15 h and for urea of 24 h (Grove & Jackson, 1995) . Therefore, based on these considerations, we would conclude that the most straightforward approach to measuring protein turnover non-invasively is to give a single oral dose of [ 15 N]glycine with a urine collection of 24 h in which the excretion and enrichment of ammonia and urea is measured. We agree with the conclusion reached by Fern and colleagues that it is most appropriate to use the average enrichment in the two end products, urea and ammonia, as the basis for deriving values for protein turnover (Fern et al, 1985a, b) . There is the added advantage that if the urine collection is extended to 24 h it is possible to obtain an estimate of apparent nitrogen balance at the same time.
In general, the results for women showed greater variability than the results for men, which raised the possibility that the cyclical metabolic changes associated with the menstrual cycle might be exerting an effect on protein turnover. The extent of this effect was assessed in the second study where six women had measurements taken at day 7 and day 14 of the cycle. For this group of women there was a signi®cant difference in protein turnover between the two time points, with¯ux at day 14 being 20% greater than at day 7. In preliminary studies we had identi®ed that these time points were most likely to be associated with the highest levels of hormones and to show changes in protein kinetics (Grove, 1992) . Day 7 is a reasonably ®xed point where the hormonal levels are likely to be low. Day 14 is around the time of ovulation, but as the timing of ovulation is variable in relation to the last menses, and best timed in relation to the following menses, the exact relation to menses is hard to de®ne. The uncertainty of these timings and the hormonal environment of individual women might account for the greater variability in the measurements made at day 14 when compared with day 7. In women taking the contraceptive pill hormonal levels are much less variable. In the small group of women taking the pill, there was no difference in protein turnover between day 7 and day 14 of the menstrual cycle, and at day 14 protein turnover was signi®cantly less than in women not taking the contraceptive pill. When the results between day 7 and day 14 are compared for the women taking the contraceptive pill, the difference between the two measures was less than 10% and therefore within any likely measurement error. From this we conclude that once the conditions under which the measurement of protein turnover is made have been standardized, much of the variability between women may be related to differences in their metabolic function, and especially their individual hormonal status.
In the third part of the study protein turnover was measured in women at two stages during pregnancy, using the minimally invasive, single dose method, with the urine collection extended to 24 h to allow full recovery of label in ammonia and urea (Grove & Jackson, 1995) , and Protein turnover in normal women AA Jackson et al the end point average used to derive values for protein turnover (Fern et al, 1985b) . There was a signi®cant increase in each aspect of protein turnover between mid and late pregnancy, but no difference when expressed relative to the body weight of the mother at 18 and 31 weeks gestation. When the difference between the two time points was considered there was a relationship between the change in the rate of protein synthesis and the body composition of the mother, which we consider might be of biological signi®cance (Duggleby & Jackson, 1999) and the potential importance of this observation is being explored in a larger group of women. The results of the present study may be compared with the measurements of protein turnover in pregnancy, in other populations, Figure 4 . Thompson and Halliday used intravenous [ 13 C]leucine to measure protein turnover in pregnant English women at three stages in pregnancy, and compared the results with a group of non-pregnant, nonlactating women (Thompson & Halliday, 1992) , and the results of the present study are very similar, suggesting that both methods are measuring similar things in a representative way. We have suggested above that the method used to study pregnant women in The Gambia tends to an overestimate of around 20% (Willommet et al, 1992) . If a correction of this order is applied to the data, the seeming marked difference between pregnant women in The Gambia, and women in England disappears ( Figure  4 , second panel), reinforcing the suggestion that a part of the apparent differences in protein turnover is methodological. Also shown in Figure 4 are the results for protein turnover in pregnant women in Jamaica, where primeintermittent oral doses of [
15 N]glycine were given with enrichment being measured in ammonia and urea in urine (de Benoist et al, 1985) . These data have been corrected to allow that the method used might fail to include adequately a contribution during pregnancy from proteins which turn over with a rapid half life (Jackson, 1987) . The recalculated results show a pattern of protein turnover with advancing pregnancy which is very similar to the results from The Gambia (Figure 4, second panel) . The suggestion remains that there are differences in late pregnancy between women in England, when compared with women in either The Gambia or in Jamaica. It will be important in future studies to use the same methods in different locations to determine whether these corrections are justi®able.
Based upon the present series of studies we conclude that it is possible to use a non-invasive approach to measure protein turnover during pregnancy with reasonable reliability. Although differences in protein turnover may appear similar when the average value is taken for populations, within any group there is usually considerable variability amongst individuals. In the present study, part of the variability in protein turnover appeared to be related to the individual body composition of the mothers. Mothers with a higher body mass index had a greater change in protein turnover between mid and late pregnancy, and this relationship was signi®cant for protein degradation (Duggleby & Jackson, 1999) . Although a part of the variability might be explained by differences in body composition, the present study suggests that for women the hormonal pro®le at the time of the study may also make a signi®cant contribution to the variability. It may be that during pregnancy these more subtle differences in aspects of protein turnover play a role in determining the mother's ability to supply adequate nutrients to her foetus. This is the basis of our current work (Duggleby & Jackson, 2000) .
